Virios Therapeutics, Inc. (VIRI): Price and Financial Metrics
VIRI Price/Volume Stats
| Current price | $0.16 | 52-week high | $1.04 |
| Prev. close | $0.14 | 52-week low | $0.13 |
| Day low | $0.14 | Volume | 42,675,600 |
| Day high | $0.21 | Avg. volume | 1,049,645 |
| 50-day MA | $0.19 | Dividend yield | N/A |
| 200-day MA | $0.33 | Market Cap | 2.98M |
VIRI Stock Price Chart Interactive Chart >
Virios Therapeutics, Inc. (VIRI) Company Bio
Virios Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1 a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA.
VIRI Price Returns
| 1-mo | N/A |
| 3-mo | -23.99% |
| 6-mo | N/A |
| 1-year | -73.68% |
| 3-year | -96.77% |
| 5-year | N/A |
| YTD | -72.17% |
| 2023 | 143.64% |
| 2022 | -95.39% |
| 2021 | -31.89% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...